[Federal Register Volume 81, Number 71 (Wednesday, April 13, 2016)]
[Notices]
[Pages 21885-21886]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-08437]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, Office of Science Policy, Office of 
Biotechnology Activities; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the meeting of the

[[Page 21886]]

National Science Advisory Board for Biosecurity (NSABB).

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: May 24, 2016.
    Time: 8:30 a.m.-4:00 p.m. Eastern.
    Agenda: (1) Finalization of NSABB findings and recommendations 
on a conceptual approach to evaluating proposed gain-of-function 
(GOF) studies; (2) discussion of next steps for U.S. government 
policy development regarding GOF studies; and (3) other business of 
the Board.
    Place: National Institutes of Health, Wilson Hall, 3rd Floor, 
Bldg. 1, 9000 Rockville Pike, Bethesda, MD 20892.
    Contact Person: Christopher Viggiani, Ph.D., Executive Director, 
NSABB, NIH Office of Science Policy, 6705 Rockledge Drive, Suite 
750, Bethesda, Maryland 20892, (301) 496-9838, [email protected].

    Under authority 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established the National Science Advisory Board for Biosecurity 
(NSABB) to provide advice regarding federal oversight of dual use 
research--defined as legitimate biological research that generates 
information and technologies that could be misused to pose a 
biological threat to public health and/or national security. The 
NSABB is currently charged with providing formal recommendations to 
the United States Government on a conceptual approach for the 
evaluation of proposed gain-of-function studies.
    The meeting will be open to the public and will also be webcast 
as space will be limited. Persons planning to attend or view via the 
webcast may pre-register online via the link provided below or by 
calling Palladian Partners, Inc. (Contact: Ida Donner or Carly 
Sullivan at 301-273-2817). Online and telephone registration will 
close at 12:00 p.m. Eastern on May 18, 2016. After that time, 
attendees may register onsite on the day of the meeting. Individuals 
who plan to attend and need special assistance, such as sign 
language interpretation or other reasonable accommodations, should 
indicate these requirements upon registration on or prior to May 18.
    Meeting materials: The meeting agenda and links to the online 
registration and webcast will be available at: http://osp.od.nih.gov/office-biotechnology-activities/biosecurity/nsabb/nsabb-meetings-and-conferences. NSABB findings and draft 
recommendations will be posted prior to the meeting. Please check 
this Web site for updates.
    Public Comments: Time will be allotted on the agenda for the 
presentation of public comments. Members of the public interested in 
presenting prepared comments relevant to the mission of the NSABB 
should indicate so upon registration. Sign-up for delivering 
prepared oral comments will be limited to one per person or 
organization representative per open comment period. Individual 
presentations will be time-limited to facilitate broad participation 
from multiple speakers. Participants viewing the meeting by webcast 
may submit questions and comments during the meeting via email sent 
to [email protected]. While time constraints and the volume of 
questions may not allow for all questions and comments submitted via 
email to be aired during the meeting, all relevant correspondence 
received will be relayed to the Board. Emailed correspondence should 
include the name, contact information, and when applicable, 
professional affiliation of the sender.
    In addition, interested persons may file written comments at any 
time with the Board via an email sent to [email protected] or by 
regular mail sent to the Contact Person listed on this notice. 
Written statements should include the name, contact information, and 
when applicable, the professional affiliation of the interested 
person. Written comments received by 10:00 a.m. Eastern on May 20, 
2016, will be relayed to the Board prior to the NSABB meeting. Any 
written comments received after this deadline will be provided to 
the Board either before or after the meeting, depending on the 
volume of comments received and the time required to process them in 
accordance with privacy regulations and other applicable Federal 
policies.
    Please Note: In the interest of security, NIH has instituted 
stringent procedures for entrance onto the NIH campus. All visitor 
vehicles, including taxis, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors will be asked to 
show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit. Please visit the NIH Visitor Security page for 
important security and campus access information.


    Dated: April 6, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-08437 Filed 4-12-16; 8:45 am]
 BILLING CODE 4140-01-P